CANPOS is a non-interventional study aiming at evaluate at the time of initial surgery the value of new serum markers to predict the occurrence of metastases in patients with early-stage non-small cell lung cancer. This would represent a rational to develop personalized follow-up and prevention strategies
Study Type
OBSERVATIONAL
Enrollment
250
Serum and plasma are collected at time of diagnosis, after surgery, and at time of progression to evaluate the value of new serum markers to predict the occurrence of metastases.
Hospices Civils de Lyon / Hôpital Neurologique Pierre Wertheimer
Bron, France
RECRUITINGThe Serum levels of osteoprotegerin
The serum levels of osteoprotegerin, as assessed by standard ELISA methods, will be measured to to evaluate at the time of initial surgery, the value of new serum markers to predict the occurrence of metastases in patients with early-stage non-small cell lung cancer.
Time frame: At the time of initial surgery
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.